关键词: clinical guidelines for psoriasis comorbidities dermatology guidelines pediatric pediatric psoriasis psoriasis psoriasis guidelines skin disease

Mesh : Adolescent Adrenal Cortex Hormones / therapeutic use Anthralin / therapeutic use Biological Products / therapeutic use Calcineurin Inhibitors / therapeutic use Cardiovascular Diseases / epidemiology Child Child, Preschool Coal Tar / therapeutic use Comorbidity Cyclosporine / therapeutic use Dermatologic Agents / therapeutic use Dyslipidemias / epidemiology Evidence-Based Medicine Humans Infant Infant, Newborn Inflammatory Bowel Diseases / epidemiology Insulin Resistance Mental Health Metabolic Syndrome / epidemiology Methotrexate / therapeutic use Nicotinic Acids / therapeutic use Obesity / epidemiology Photochemotherapy Psoriasis / drug therapy epidemiology psychology Retinoids / therapeutic use

来  源:   DOI:10.1016/j.jaad.2019.08.049   PDF(Sci-hub)

Abstract:
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.
摘要:
牛皮癣是一种慢性,多系统,影响大约1%儿童的炎症性疾病,发病最常见于青春期。该指南解决了银屑病治疗中出现的重要临床问题,并提供了基于证据的建议。将注意小儿牛皮癣患者,认识到独特的生理学,药代动力学,以及18岁以下患者的患者-父母-提供者互动。这里回顾的主题反映了成人指南部分中讨论的主题,排除那些无关紧要的话题,或者缺乏足够的信息,儿科患者。
公众号